Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer
暂无分享,去创建一个
P. Pourquier | F. Joly | N. Houédé | C. Bellera | B. Lortal | G. Roubaud | C. Pfister | L. Mourey | A. Cazeau | M. Pulido | L. Védrine | H. Mahammedi | Alejandro Goberna